This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Hepatitis G virus (HGV)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

In Britain no agent can be identified in 50% of cases of acute liver failure of apparently viral cause. Search therefore continues for new hepatitis viruses

Flavivirus-like agents have been isolated including GB viruses, GB-A, GB-B and GB-C.

Hepatitis G virus (HGV) (also called hepatitis GB virus-C) is a single-stranded, positive-sense RNA virus that is, like hepatitis C virus (HCV), a member of the Flaviviridae family. In common with both HBV and HCV, it is hepatotropic and has a global distribution

  • HGV genome is comprised of approximately 9400 nucleotides, and codes for a single large polyprotein
  • exposure to blood products is a recognized route of acquisition of HGV infection in humans, and the virus is often detectable in the serum of patients who have received multiple blood transfusions, as well as in intravenous drug abusers
  • prevalence of HGV viremia in chronic non-A-E liver disease of 3-15% is not greater than that of persistent HGV RNA in nonviral chronic liver disease. Accordingly, conclusive evidence that HGV causes liver disease and hence qualifies to be a hepatitis virus is lacking

Reference:

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.